CPI-818

· Corvus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CPI-818, covering 2025-04-16 to 2025-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma [Phase 1]